Episode 118: Remdesivir’s controversial cost, early vaccine promise, and AI at the end of life

What’s a fair price for remdesivir? How do we know whether vaccines work? And does AI have a place in end-of-life care?

Om Podcasten

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.